Averica is an analytical development CRO with specialized expertise in small molecule analysis and purification.
Dr. Berger previously served as project manager at PCI Synthesis, a CMO, where she managed multi-million dollar projects manufacturing APIs. She was also vice president and a co-founder of Pion Inc., an instrumentation company and CRO, where she developed and grew markets for instrumentation, established a contract research lab, and led the sale of Pion to a private investment group.
“We are excited to welcome Cindy, who will provide significant insight and guidance to our growth as an analytical development company,” said Dr. Kiplinger. “Cindy will be exploring new ways to expand our capabilities and enhance the value we bring to clients. She will also oversee the standardization of many of our processes as we move toward ISO 17025 certification and add GMP analytical capabilities. Her significant experience and strong understanding of the analytical services market, coupled with her strong operations, financial, and business background, make her an essential asset to the future of Averica.”